Form 4: Alexander & Baldwin Exec Sells Shares

Alexander & Baldwin's Executive VP, Meredith J. Ching, sold 700 shares of common stock under a Rule 10b5-1 plan.

Summary

• Meredith J. Ching, Executive VP of External Affairs at Alexander & Baldwin, Inc. (ALEX), reported a transaction involving the company's common stock.
• On December 10, 2025, Ching disposed of 700 shares of common stock.
• The shares were sold at a weighted average price of $20.8882 per share, with individual transaction prices ranging from $20.85 to $20.915.
• This sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
• Following the transaction, Ching directly beneficially owns 145,449 shares of common stock.
• Additionally, 213 shares are indirectly owned by Ching's spouse, and 781.571 shares are indirectly owned through TCESOP.

Sentiment

Score: 5

Explanation: The sale of shares by an executive, while executed under a Rule 10b5-1 plan (indicating it was pre-scheduled and not based on new material non-public information), is generally viewed neutrally to slightly negatively by the market as it reduces insider ownership.

Negatives

• An Executive VP sold 700 shares of company common stock, which reduces insider ownership.

Future Outlook

na

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: The transaction represents a minor reduction in direct insider ownership, though its execution under a Rule 10b5-1 plan mitigates concerns about its timing.

Key Dates

Recommendation

The sale of 700 shares by an executive, while notable, was executed under a Rule 10b5-1 trading plan, suggesting it was pre-scheduled and not indicative of new material information. This type of transaction typically does not warrant a change in investment recommendation unless it is part of a larger pattern of insider selling or a significant portion of the executive's holdings.

Keywords

Alexander & Baldwin, ALEX, Meredith J. Ching, Insider Trading, Form 4, Stock Sale, Rule 10b5-1, Executive VP